| Pharmaceutical active ingredients: |
| Erythromycin Ethylsuccinate |
| Available forms, composition and doses of E-Mycin: |
| Suspension; Oral; Erythromycin Ethylsuccinate 200 mg / 5 mlSuspension; Oral; Erythromycin Ethylsuccinate 400 mg / 5 mlTablets, Delayed Release; Oral; Erythromycin Ethylsuccinate 250 mgTablets, Delayed Release; Oral; Erythromycin Ethylsuccinate 333 mgTablets, Delayed Release; Oral; Erythromycin Ethylsuccinate 400 mgTablets; Oral; Erythromycin Ethylsuccinate 250 mg |
| E-Mycin medical category: |
| Human:Acne treatment preparationsAntibacterialsErythromycinsEye anti-infectives and antisepticsMacrolidesTopical antibiotics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J01FA01 - ErythromycinS01AA17 - Erythromycin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| PfizerAbbottAlphapharmDocmedPacific PharmaceuticalsPerrigoThemis Pharmaceuticals |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Biolid | Erythromycin Ethylsuccinate | Belmac Laboratorios |
| Bronsema | Erythromycin Ethylsuccinate | Edigen |
| Durapaediat | Erythromycin Ethylsuccinate | Merck |
| E.E.S. | Erythromycin Ethylsuccinate | Abbott; Arbor Pharmaceuticals; Pfizer |
| EES | Erythromycin Ethylsuccinate | Abbott; Amdipharm; Zuellig Pharma |
| E-Mycin E | Erythromycin Ethylsuccinate | Pfizer |
| Erisine | Erythromycin Ethylsuccinate | Lafedar Laboratorios |
| Eritrocina | Erythromycin Ethylsuccinate | Abbott |
| Eritrogobens | Erythromycin Ethylsuccinate | Normon |
| Eritromicina | Erythromycin Ethylsuccinate | Chile Laboratorios |